BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25586233)

  • 1. [Chemotherapy-induced neuropathy].
    Boehmerle W; Huehnchen P; Endres M
    Nervenarzt; 2015 Feb; 86(2):156-60. PubMed ID: 25586233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
    Hershman DL; Lacchetti C; Dworkin RH; Lavoie Smith EM; Bleeker J; Cavaletti G; Chauhan C; Gavin P; Lavino A; Lustberg MB; Paice J; Schneider B; Smith ML; Smith T; Terstriep S; Wagner-Johnston N; Bak K; Loprinzi CL;
    J Clin Oncol; 2014 Jun; 32(18):1941-67. PubMed ID: 24733808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy-induced peripheral neuropathy and neuropathic pain].
    Schuler U; Heller S
    Schmerz; 2017 Aug; 31(4):413-425. PubMed ID: 28293734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.
    Ewertz M; Qvortrup C; Eckhoff L
    Acta Oncol; 2015 May; 54(5):587-91. PubMed ID: 25751757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nursing care of chemotherapy-induced peripheral neuropathy].
    Hsu SY; Lu CH; Chen SZ; Jane SW
    Hu Li Za Zhi; 2015 Apr; 62(2):84-8. PubMed ID: 25854951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced peripheral neuropathy: a review of recent findings.
    Kim PY; Johnson CE
    Curr Opin Anaesthesiol; 2017 Oct; 30(5):570-576. PubMed ID: 28708674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy.
    Derman BA; Davis AM
    JAMA; 2021 Sep; 326(11):1058-1059. PubMed ID: 34546311
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy-induced peripheral neuropathies in hematological malignancies.
    Jongen JL; Broijl A; Sonneveld P
    J Neurooncol; 2015 Jan; 121(2):229-37. PubMed ID: 25326770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy-induced peripheral neuropathy].
    Noguchi E; Maeda Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-induced neuropathy.
    Windebank AJ; Grisold W
    J Peripher Nerv Syst; 2008 Mar; 13(1):27-46. PubMed ID: 18346229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of chemotherapy-evoked painful peripheral neuropathies.
    Authier N; Balayssac D; Marchand F; Ling B; Zangarelli A; Descoeur J; Coudore F; Bourinet E; Eschalier A
    Neurotherapeutics; 2009 Oct; 6(4):620-9. PubMed ID: 19789067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice.
    Wickham R
    Clin J Oncol Nurs; 2007 Jun; 11(3):361-76. PubMed ID: 17623621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced neuropathies-a growing problem for patients and health care providers.
    Banach M; Juranek JK; Zygulska AL
    Brain Behav; 2017 Jan; 7(1):e00558. PubMed ID: 28127506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.
    Verstappen CC; Heimans JJ; Hoekman K; Postma TJ
    Drugs; 2003; 63(15):1549-63. PubMed ID: 12887262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on Chemotherapy-Induced Peripheral Neuropathy.
    Cioroiu C; Weimer LH
    Curr Neurol Neurosci Rep; 2017 Jun; 17(6):47. PubMed ID: 28421360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of multiple myeloma: thalidomide-, bortezomib-, and lenalidomide-induced peripheral neuropathy.
    Koeppen S
    Oncol Res Treat; 2014; 37(9):506-13. PubMed ID: 25231692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of duloxetine for Paclitaxel-induced peripheral neuropathy treatment in gynecological cancer patients.
    Otake A; Yoshino K; Ueda Y; Sawada K; Mabuchi S; Kimura T; Kobayashi E; Isobe A; Egawa-Takata T; Matsuzaki S; Fujita M; Kimura T
    Anticancer Res; 2015 Jan; 35(1):359-63. PubMed ID: 25550572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment by adding duloxetine to pregabalin for peripheral neuropathy induced by paclitaxel.
    Takenaka M; Iida H; Matsumoto S; Yamaguchi S; Yoshimura N; Miyamoto M
    Am J Hosp Palliat Care; 2013 Nov; 30(7):734-6. PubMed ID: 23064035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient perceptions associated with chemotherapy-induced peripheral neuropathy.
    Tofthagen C
    Clin J Oncol Nurs; 2010 Jun; 14(3):E22-8. PubMed ID: 20529785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.